Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy

[1]  W. Bauer,et al.  Advances in managing heart failure and suddencardiac death: reverse remodelling by drugs? , 2003 .

[2]  A. Maggioni.  Overview of recent drug studies in chronic heart failure , 2003 .

[3]  P. Nieminen,et al.  Clinical utility and outcome of HFE-genotyping in the search for hereditary hemochromatosis. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[4]  C. Arosio,et al.  Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry. , 2003, Haematologica.

[5]  P. Stål,et al.  Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls , 2002, Gut.

[6]  W. McKenna,et al.  Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance , 2002, European journal of heart failure.

[7]  Miriam Parker,et al.  Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. , 2002, Cleveland Clinic journal of medicine.

[8]  J. Dooley,et al.  Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. , 2002, Journal of hepatology.

[9]  R. McKelvie,et al.  Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. , 2002, Journal of the American College of Cardiology.

[10]  L. Tiret,et al.  Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study , 2001 .

[11]  W. Sly,et al.  Molecular aspects of iron absorption and HFE expression. , 2001, Gastroenterology.

[12]  A. Mansur,et al.  Hemochromatosis gene variants in patients with cardiomyopathy. , 2001, The American journal of cardiology.

[13]  W. Burke,et al.  HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. , 2001, American journal of epidemiology.

[14]  P. Koistinen,et al.  HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia , 2001, Transfusion.

[15]  V. Felitti,et al.  The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic , 2000, Annals of Internal Medicine.

[16]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[17]  W. Mckenna,et al.  Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy , 2000, Heart.

[18]  R. Hegele,et al.  Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis , 1999, Nature Genetics.

[19]  J. Barton,et al.  Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. , 1999, Blood cells, molecules & diseases.

[20]  C. Férec,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS HFE Mutations Analysis in 711 Hemochromatosis Probands: Evidence for S65C Implication in Mild Form of Hemochromatosis , 2016 .

[21]  C. Datz,et al.  Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. , 1997, Journal of hepatology.

[22]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[23]  L. Mestroni,et al.  Genetic factors in dilated cardiomyopathy. , 1996, Archives des maladies du coeur et des vaisseaux.

[24]  C. Limas.  Autoimmunity in dilated cardiomyopathy and the major histocompatibility complex. , 1996, International journal of cardiology.

[25]  A. Gavazzi,et al.  The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. SPIC (Italian Multicenter Cardiomyopathy Study) Group. , 1993, American heart journal.

[26]  R. De Maria,et al.  [Clinical and prognostic significance of echocardiographic parameters in dilated cardiomyopathy: a prospective study on 225 patients. The Italian Multicenter Study of Cardiomyopathies Group]. , 1992, Giornale italiano di cardiologia.

[27]  W. Abelmann,et al.  Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. , 1992, The American journal of cardiology.

[28]  J. Jais,et al.  Factors predicting mortality in idiopathic dilated cardiomyopathy. , 1990, European heart journal.

[29]  M. Moeschberger,et al.  Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.